missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Reactivos para análisis de proteínas
  4. Moléculas pequeñas bioactivas
  5. Tocris Bioscience™ Vandetanib

Tocris Bioscience™ Vandetanib
GREENER_CHOICE

Código de producto. 18795836
Cambiar vista
Click to view available options
Cantidad:
10 mg
50 mg
Tamaño de la unidad:
10 miligramos
50 miligramos
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Código de producto. Cantidad unitSize
18795836 10 mg 10 miligramos
18757046 50 mg 50 miligramos
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Este artículo no se puede devolver. Vea la política de devoluciones
Código de producto. 18795836 Proveedor Tocris Bioscience™ N.º de proveedor 7497/10

Please to purchase this item. Need a web account? Register with us today!

Este artículo no se puede devolver. Vea la política de devoluciones

Descripción

Potent VEGFR-2 inhibitor, also inhibits EGFR and RET oncoproteins activity

Vandetanib is a potent VEGFR-2 inhibitor (IC50 = 0.04 μM), and inhibitor of EGFR (IC50 = 0.5 μM). Vandetanib potently inhibits (IC50 = 100 nM) RET oncoprotein activity in human thyroid cancer. Vandetanib displays anti-angiogenic properties in human nasopharyngeal carcinoma in mice model. Vandetanib is orally available and effective in vivo.
TRUSTED_SUSTAINABILITY

Especificaciones

Nombre del producto químico o material N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine
CAS 443913-73-3
Cantidad 10 mg
Objetivo VEGF Receptor Inhibitors
Fórmula molecular C22H24BrFN4O2
Pureza 0.98
Título del producto
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.